Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...

Scientists have made a discovery which could lead to the first change in standard liver cancer treatment in 20 years. Two ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a leading biopharmaceutical company focused on patient-centric solutions, today shared encouraging interim safety and efficacy results from its Phase 2a ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

GSK has gained US Food and Drug Administration (FDA) breakthrough therapy designation (BTD) for its B7-H3-targeted ...

A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...